Smile Digital Health Gets ISO 27017 Certified
Smile once again shows its dedication to true interoperability, which relies on safe data sharing via the cloud, with new...
Healthcare
Pasadena Villa Expands Mental Health Treatment Services With New Residential Facility in Michigan
BRENTWOOD, TN / ACCESSWIRE / October 22, 2024 / Odyssey Behavioral Healthcare, a leading provider of mental health, addiction, and...
NCQA Celebrates Health Care Quality Week by Highlighting Quality Innovators
Three Health Innovation Award recipients, recognized for excellence in accelerating health equity and delivery system design, include Elevance Health, UniCare...
Sonoma Pharmaceuticals Announces Expanded Partnership with Global Healthcare Distributor for Distribution of Wound Care Products in Canada
BOULDER, CO / ACCESSWIRE / October 22, 2024 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing...
New Research on Charity Care and the 340B Program From the Health Equity Collaborative
The State of U.S. Charity Care: Solutions to Improve the Patient Experience and Achieve More Equitable Health OutcomesWASHINGTON, DC /...
From Struggles to Solutions: How Kennett Schools Transformed Student Health Coordination With CrossTx
School districts that help students receive mental health and healthcare treatment create safer, more inclusive learning environments. By making care...
UKs Largest Medical Cannabis Deal Signed by Releaf
Historic Multi-Million-Pound Deal is the UK's Largest Ever Medical Cannabis ContractThe UK's fastest-growing medical cannabis provider has signed a multi-million-pound...
Parexel Names Keri Mattox Chief Business Officer
Healthcare executive to lead company’s business operations and growth strategyDURHAM, N.C., Oct. 22, 2024 (GLOBE NEWSWIRE) -- Parexel, one of...
QHSLab, Inc. Welcomes Dr. Juan D. Oms, MD, FAPA, as Medical Advisor for Psychiatry and Behavioral Health
WEST PALM BEACH, FL, Oct. 22, 2024 (GLOBE NEWSWIRE) -- QHSLab, Inc. (the "Company") (OTCQB: USAQ), a leader in digital...
SeaStar Medical to Distribute QUELIMMUNE Directly to Hospital Customers
DENVER, Oct. 22, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary...
HealthLynked Announces Strategic Partnership with 3X4 Genetics to Enhance Member Offerings
NAPLES, Fla., Oct. 22, 2024 (GLOBE NEWSWIRE) -- -- via IBN -- HealthLynked Corp. (OTCQB: HLYK), a leading global healthcare network...
Celularity Provides Corporate Update
FLORHAM PARK, N.J., Oct. 22, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”), a regenerative and cellular medicine company, has...
Florida Oncology and Hematology and American Oncology Network Opens New Location in Cape Coral, Welcomes Medical Director, Dr. Van den Bergh, and Drs. Venkata Parsa, and Shivtaj Mann
Board-certified medical oncologists Magali Van den Bergh, MD, Venkata Parsa, MD, and Shivtaj Mann, DO join the Cape Coral physician...
Taysha Gene Therapies to Present Biodistribution Data from an Analysis Evaluating AAV9 Gene Therapy Delivery at the Upcoming 31st Annual ESGCT Congress
Data from an analysis of five NHP studies showed lumbar IT administration led to widespread and consistent biodistribution of AAV9...
Recursion announces first patient dosed in Phase 2 clinical study of REC-3964, a potential first-in-class, oral, non-antibiotic small molecule for recurrent Clostridioides difficile infection
REC-3964 is Recursion’s first new chemical entity developed using the RecursionOS.REC-3964 represents a novel, non-antibiotic approach with a unique mechanism...
Grifols Partners with BARDA for Proof-of-Concept Testing of Ocular Immunoglobulin as Treatment for Sulfur Mustard-Induced Eye Injury
Initiative will test Grifols ocular surface immunoglobulin (OSIG) eye drops to evaluate their nonclinical efficacy in neutralizing symptoms from exposure...
Indaptus Therapeutics Announces Clinical Supply Agreement with BeiGene to Evaluate Novel Cancer Treatment Combinations
Planned industry first clinical trial combining BeiGene's checkpoint inhibitor tislelizumab with Indaptus’ broadly targeted, short duration systemic immune stimulator Decoy20...
Viemed Healthcare Announces Third Quarter 2024 Earnings Conference Call Details
LAFAYETTE, La., Oct. 22, 2024 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD), a national leader in...
ProPhase Labs to Present at the 2024 ThinkEquity Conference
GARDEN CITY, NY, Oct. 22, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (the “Company” or “ProPhase”), a next...
InnovAge to Announce Fiscal First Quarter 2025 Financial Results and Host Conference Call Tuesday, November 5, 2024
DENVER, Oct. 22, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in...